I13005—Immunology/ Rheumatology

Contact:

Mentor/Principal InvestigatorRobert P. Kimberly, M.D. Professor  Mailing address: SHEL 176, 1530 3RD AVENUE S BIRMINGHAM AL 35294-2182  Telephone: (205) 934-0245  E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Immunogenetics and Functional Genomics

Research opportunities are available in cellular and molecular immunology, emphasizing genetic variation of immune response genes and the impact on immune system function, including the predisposition to autoimmune and immune-mediated inflammatory diseases and the characteristics of host responses to infectious agents. Both human and non-human model systems form the basis for study.

The primary emphasis of the program is the identification and understanding of naturally occurring, genomically encoded variants of immune response genes. Mentors are involved in both their own research programs and in the care of patients with autoimmune and immune-mediated inflammatory diseases, thus providing an opportunity for translational work between model systems and human immunology. Opportunities in human biology and disease are available in autoimmune and immune-mediated inflammatory diseases, malignant diseases, host-defense defense including vaccine development, and transplantation immunology. Outstanding investigator-based and core-based facilities are available. Resources include state-of-the-art high-speed flow cytometry, high resolution imaging (confocal, FRET, standard and cryo-election microscopy), nucleic acid and protein sequencing, hybridoma/phage display antibody production, and transgenic/ES cell mouse facilities.

Postdoctoral trainees with an M.D., Ph.D. or equivalent terminal degree are selected on the basis of prior academic and research performance, letters of recommendation, and personal interviews. Successful candidates will demonstrate a strong commitment to a research and teaching career in investigative biomedical sciences. For further information, please contact Dr. Robert Kimberly, E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .

UAB News

  • A team of UAB business students and Birmingham high school students is analyzing living conditions in Birmingham’s 6th District.Birmingham City Schools Superintendent Craig Witherspoon visits with Collat business scholars to assist with research for their summer project.Student scholars from the Collat School of Business at the University of Alabama at Birmingham are working with area high school students this month on a research project to discover opportunities to improve social and economic conditions in Birmingham. This...

  • States that allow officers to pull over a driver for texting while driving saw fewer deaths than those that use secondary enforcement of texting bans.Click the image to enlargeResearchers at the University of Alabama at Birmingham School of Public Health examined the impact texting-while-driving laws have had on roadway crash-related fatalities, and the findings are published in the August issue of the American Journal of Public Health. Of drivers in the United States ages 18-64 years,...

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...